Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) A
Post# of 29
(Total Views: 197)
Posted On: 09/04/2018 6:04:11 PM
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Awarded Full Depository Trust Company Eligibility
- Phivida has been awarded DTC and CNS eligibility for its common shares
- Company is a premium food and beverage leader in the use of infused cannabinoids
- Phivida’s mission is to help lessen the world’s dependence on pharmaceuticals
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage business based in Vancouver, British Columbia. The company infuses all of its products with organic cannabinoids from hemp, and it offers premium beverages and clinical products for everyday health.
Phivida recently announced that it has been awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the OTCQX® Best Market under the symbol “PHVAF” in the U.S. (http://nnw.fm/Py9Lz).
DTC’s emphasis is worldwide trading activity. It processes trillions of dollars of securities transactions daily. DTC provides an electronic process of clearing securities that expedites the receipt of stock and cash while speeding up the settlement process. CNS is an automated book-entry accounting system. Its focus is on centralizing the settlement of security transactions. It does so while maintaining an organized flow of security and money balances between those participating in the market.
Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.
Regarding its business, Phivida’s belief is that overall body health and balance are best maintained through whole plant nutrition and natural ingredients. Phivida sources its products from premier organic hemp and natural ingredients. These products are third-party lab tested for quality, purity and potency at world-class facilities. Hemp is a source of full-spectrum cannabinoids and is high CBD/low THC.
Phivida’s product line-up includes beverages, capsules and tinctures. Oki is its newest brand of hemp extract-infused flavored iced teas, flavor-infused waters and tinctures and capsules. In addition, the company offers the Vida+ line of premium hemp-infused products, including hemp oil extract and hemp oil capsules.
Phivida is cGMP-compliant (Current Good Manufacturing Practice) to ensure pharmaceutical quality. The company fuses ancient eastern traditions of whole plant medicine with contemporary western principles of naturopathic science. Phivida employs encapsulation technology. It converts phytocannabinoids into a water-soluble delivery format. This format improves bioavailability and timed released within the body.
Recently, Phivida signed an agreement with Acosta’s National Specialty Sales division, which gives the company access to 2,400 national specialty retailers throughout the United States.
Moreover, Phivida and WeedMD (OTC: WDDMF) have signed a final definitive Joint Venture (JV) agreement. This agreement is to develop and operate Cannabis Beverages, Inc. (CanBev), with each company retaining 50 percent of the Class A shares in CanBev.
For more information, visit the company’s website at www.Phivida.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Phivida has been awarded DTC and CNS eligibility for its common shares
- Company is a premium food and beverage leader in the use of infused cannabinoids
- Phivida’s mission is to help lessen the world’s dependence on pharmaceuticals
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage business based in Vancouver, British Columbia. The company infuses all of its products with organic cannabinoids from hemp, and it offers premium beverages and clinical products for everyday health.
Phivida recently announced that it has been awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the OTCQX® Best Market under the symbol “PHVAF” in the U.S. (http://nnw.fm/Py9Lz).
DTC’s emphasis is worldwide trading activity. It processes trillions of dollars of securities transactions daily. DTC provides an electronic process of clearing securities that expedites the receipt of stock and cash while speeding up the settlement process. CNS is an automated book-entry accounting system. Its focus is on centralizing the settlement of security transactions. It does so while maintaining an organized flow of security and money balances between those participating in the market.
Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.
Regarding its business, Phivida’s belief is that overall body health and balance are best maintained through whole plant nutrition and natural ingredients. Phivida sources its products from premier organic hemp and natural ingredients. These products are third-party lab tested for quality, purity and potency at world-class facilities. Hemp is a source of full-spectrum cannabinoids and is high CBD/low THC.
Phivida’s product line-up includes beverages, capsules and tinctures. Oki is its newest brand of hemp extract-infused flavored iced teas, flavor-infused waters and tinctures and capsules. In addition, the company offers the Vida+ line of premium hemp-infused products, including hemp oil extract and hemp oil capsules.
Phivida is cGMP-compliant (Current Good Manufacturing Practice) to ensure pharmaceutical quality. The company fuses ancient eastern traditions of whole plant medicine with contemporary western principles of naturopathic science. Phivida employs encapsulation technology. It converts phytocannabinoids into a water-soluble delivery format. This format improves bioavailability and timed released within the body.
Recently, Phivida signed an agreement with Acosta’s National Specialty Sales division, which gives the company access to 2,400 national specialty retailers throughout the United States.
Moreover, Phivida and WeedMD (OTC: WDDMF) have signed a final definitive Joint Venture (JV) agreement. This agreement is to develop and operate Cannabis Beverages, Inc. (CanBev), with each company retaining 50 percent of the Class A shares in CanBev.
For more information, visit the company’s website at www.Phivida.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)